Insider Watch Reporter: Aceto Corporation (NASDAQ:ACET)’s Stock Insider Selling – Steven Rogers Sells 2,400 Shares

November 23, 2016 - By Marguerite Chambers

Insider Watch Reporter: Aceto Corporation (NASDAQ:ACET)'s Stock Insider Selling   Steven Rogers Sells 2,400 Shares

Steven Rogers Insider Sell

Two days ago, the SVP – CHIEF LEGAL OFFICER of Aceto Corp, Mr. Steven Rogers, sold amount of shares – 2,400, amounting to $46,878 US Dollars, based on $19.5 per every share. Steven Rogers currently has rights to 0.07% of Aceto Corp’s total market capitalization with ownership of 21,280 shares.  This insider deal, was executed on 23/11/2016. It’s free at your disposal at the SEC’s website and can be accessed at this page.

Insitutional Activity: The institutional sentiment increased to 1.22 in Q2 2016. Its up 0.36, from 0.86 in 2016Q1. The ratio increased, as 16 funds sold all Aceto Corporation shares owned while 49 reduced positions. 11 funds bought stakes while 45 increased positions. They now own 23.91 million shares or 7.56% less from 25.86 million shares in 2016Q1.

Goldman Sachs Gp Inc accumulated 35,524 shares or 0% of the stock. Capstone Asset Mgmt last reported 0.01% of its portfolio in the stock. Moreover, Tradewinds Ltd Liability Co has 0.02% invested in Aceto Corporation (NASDAQ:ACET) for 14,948 shares. Ameriprise Finance Inc has invested 0% of its portfolio in Aceto Corporation (NASDAQ:ACET). Pnc Financial Serv Incorporated last reported 0% of its portfolio in the stock. The Texas-based Sunbelt Securities Inc has invested 0% in Aceto Corporation (NASDAQ:ACET). Putnam Invests Lc holds 0% of its portfolio in Aceto Corporation (NASDAQ:ACET) for 56,549 shares. Keeley Asset has 47,700 shares for 0.04% of their US portfolio. Moreover, Deutsche Bankshares Ag has 0% invested in Aceto Corporation (NASDAQ:ACET) for 98,535 shares. The Japan-based Nomura Inc has invested 0.01% in Aceto Corporation (NASDAQ:ACET). The Connecticut-based Zebra Capital Management Ltd Liability Com has invested 0.22% in Aceto Corporation (NASDAQ:ACET). Phocas Financial Corp accumulated 0.81% or 505,259 shares. Nationwide Fund Advisors last reported 20,896 shares in the company. Motley Fool Wealth Mngmt Llc holds 0.32% of its portfolio in Aceto Corporation (NASDAQ:ACET) for 133,520 shares. Manufacturers Life Insurance The reported 19,930 shares or 0% of all its holdings.

Insider Transactions: Since May 26, 2016, the stock had 0 insider purchases, and 31 sales for $3.14 million net activity. 1,321 shares were sold by Kippley Terry, worth $26,222. GUCCIONE SALVATORE J SR sold $5,106 worth of stock. Another trade for 4,200 shares valued at $97,100 was sold by BRITTON WILLIAM N. ROTH DOUGLAS A sold $205,520 worth of stock. EILENDER ALBERT L sold $257,645 worth of Aceto Corporation (NASDAQ:ACET) on Thursday, September 1. On Monday, June 6 DEBENEDITTIS FRANK sold $154,110 worth of the stock or 6,810 shares. $81,551 worth of Aceto Corporation (NASDAQ:ACET) was sold by Alaimo Charles John on Wednesday, July 6.

About 48,213 shares traded hands. Aceto Corporation (NASDAQ:ACET) has declined 19.89% since April 21, 2016 and is downtrending. It has underperformed by 25.22% the S&P500.

Aceto Corporation is engaged in the marketing, sales and distribution of finished dosage form generic pharmaceuticals, nutraceutical products, pharmaceutical active ingredients and intermediates, specialty performance chemicals inclusive of agricultural intermediates and agricultural protection products. The company has a market cap of $587.50 million. The Company’s business is organized along product lines into three divisions: Human Health, Pharmaceutical Ingredients and Performance Chemicals. It has a 19.63 P/E ratio. As of June 30, 2016, it distributed over 1,100 chemical compounds used primarily as finished products or raw materials in the agricultural, coatings and industrial chemical industries.

According to Zacks Investment Research, “Aceto Corporation markets, sells and distributes finished dosage form generics, nutraceutical products, pharmaceutical intermediates and active ingredients, agricultural protection products and specialty chemicals. The company’s operating segment consists of Human Health, Pharmaceutical Ingredients and Performance Chemicals. Human Health segment supplies raw materials used in the production of nutritional and packaged dietary supplements. It markets and distributes its generic prescription and over the counter pharmaceutical products. Pharmaceutical Ingredients segment offers active pharmaceutical ingredients and pharmaceutical intermediates. Performance Chemicals segment provides specialty chemicals. It serves chemical, agricultural, human health and pharmaceutical industries. The company operates primarily in United States, Europe, and Asia. Aceto Corporation and is headquartered in Port Washington, New York.”

Analysts await Aceto Corporation (NASDAQ:ACET) to report earnings on February, 2. They expect $0.35 earnings per share, down 2.78% or $0.01 from last year’s $0.36 per share. ACET’s profit will be $10.41 million for 14.11 P/E if the $0.35 EPS becomes a reality. After $0.28 actual earnings per share reported by Aceto Corporation for the previous quarter, Wall Street now forecasts 25.00% EPS growth.

More notable recent Aceto Corporation (NASDAQ:ACET) news were published by: Fool.com which released: “Why Shares of Aceto Corporation Plunged 23% Today” on August 26, 2016, also Streetinsider.com with their article: “ACETO Corp (ACET) Announces $412M Acquisition of Certain Assets from Citron ..” published on November 03, 2016, Globenewswire.com published: “ACETO Corporation Schedules Fourth Quarter & Fiscal 2016 Financial Results ..” on August 12, 2016. More interesting news about Aceto Corporation (NASDAQ:ACET) were released by: Globenewswire.com and their article: “ACETO Corporation Schedules First Quarter Fiscal 2017 Financial Results News ..” published on October 21, 2016 as well as Globenewswire.com‘s news article titled: “ACETO Corporation Announces $125 Million Convertible Notes Offering” with publication date: November 09, 2015.

ACET Company Profile

Aceto Corporation (Aceto), incorporated on June 13, 1947, is engaged in the marketing, sales and distribution of finished dosage form generic pharmaceuticals, nutraceutical products, pharmaceutical active ingredients and intermediates, specialty performance chemicals inclusive of agricultural intermediates and agricultural protection products. The Company’s business is organized along product lines into three divisions: Human Health, Pharmaceutical Ingredients and Performance Chemicals. As of June 30, 2016, the Company distributed over 1,100 chemical compounds used primarily as finished products or raw materials in the pharmaceutical, nutraceutical, agricultural, coatings and industrial chemical industries. The Firm has presence in China, Germany, France, The Netherlands, Singapore, India, Hong Kong, Philippines, the United Kingdom and the United States.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Tags: , ,

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>